Skip to main content

Table 1 Characteristic of the three subject groups on important clinical variables related to cocaine use.

From: Refining multivariate disease phenotypes for high chip heritability

Variable

Group1

250(14.27)

Group2

339(19.35)

Group3

926(52.85)

Group4

237(13.53)

Tolerance to cocaine

124(49.60)

80(23.60)

807(87.15)

123(51.90)

Withdrawal from cocaine

14(5.60)

275(81.12)

813(87.80)

192(81.01)

Using cocaine in larger amounts or over longer period than intended

249(99.60)

323(95.28)

816(88.12)

103(43.46)

Persistent desiring or unsuccessful cutting down cocaine use

223(89.20)

326(96.17)

839(90.60)

233(98.31)

Great amount of time spent in activities related to cocaine

240(96.00)

290(85.55)

823(88.88)

82(34.60)

Gave up or reduced important activities because of cocaine use

170(68.00)

212(62.54)

806(87.04)

156(65.82)

Cocaine use despite knowledge of problems likely caused by cocaine

209(83.60)

315(92.92)

817(88.23)

170(71.73)

Number of CD criteria endorsed

4.92(1.07)

5.37(1.08)

6.18(2.10)

4.47(1.50)

Age when first used cocaine

21.93(6.34)

22.32(6.51)

21.44(5.75)

22.97(8.42)

Age onset of DSM4 cocaine dependence

28.24(7.88)

28.31(7.95)

26.63(6.70)

28.32(8.06)

Transition time in years from first cocaine use to first CD diagnosis

8.01(12.05)

8.07(12.91)

12.15(21.30)

15.19(24.65)

  1. N (%) is shown for the first seven binary variables, where N is the number of subjects who are positive on the corresponding variable within a group and % is the percentage of N in the group.
  2. µ(σ2) is shown for the last four continuous variable, where µ is the group mean and σ2 the standard deviation.